William Hirschman has joined the leadership team of contract research organisation (CRO) Worldwide Clinical Trials.
He will be Executive Vice President and head of Global Business Development. Hirschman will lead Worldwide’s growing business development organisation, a large global team that includes sales, sales operations, and proposal development.
Hirschman’s 25-year career has included a range of leadership roles within CROs, pharmaceutical and scientific companies, where he has helped to lead efforts to take several businesses to more than $bn in annual sales.
Most recently, Hirschman served as Global Vice President of Commercial Operations at Fisher Clinical Services, a company specialising in providing clinical trial supplies and logistics for the pharmaceutical and biopharmaceutical industries.
Prior to his time at Fisher, Hirschman managed sales, marketing and business development for the Clinical Pharmacology Phase I, Clinical Phase II-III and Interactive Voice Response (IVR) business units of Covance.
Previously, he held sales and marketing leadership roles at Genomics, IBAH (Omnicare Research Group), VWR International and he began his career in sales at Baxter Healthcare.
Hirschman holds a Bachelor of Arts degree in Communications Arts and Sciences and General Business from Michigan State University.
Peter Benton, President and COO at Worldwide. “We selected Bill to join our leadership team because he has the right combination of industry expertise and experience, with the strategic mind-set to bring it all together.”
Hirschman said. “Worldwide’s leadership team has set forth a clear and exciting vision for the future. The market opportunity for a company like Worldwide is undeniable and the business development organisation is made up of a team of experienced, successful professionals.”
